Compare Agilysys Inc (AGYS) vs Aspen Aerogels Inc (ASPN) Price & Performance

Agilysys (AGYS) trades at $107.35, up 0.73% today, with a neutral technical signal and bullish moving averages. The company reported strong Q1 2027 results, beating earnings estimates and raising its full-year outlook, driven by subscription growth and AI-driven modules. Financials show improving profitability, with net income margin rising to 12.99% in 2026 from 8.42% in 2025, though valuation ratios like P/E of 70.63 remain elevated.

The outlook is positive, with 100% analyst buy ratings and a $118.33 consensus price target implying upside. Key risks include high valuation sensitivity and execution challenges in deploying new technology, while opportunities lie in sustained subscription revenue growth and market expansion in hospitality software.

ASPN trades at $6.15, up 0.16% today, with a bullish technical signal from moving averages and ADX. The company reported Q2 2026 revenue of $29.5M, up 81% sequentially, and provided optimistic Q3 guidance of $65-80M revenue. However, it remains unprofitable with a net income margin of -62.45% and negative ROE of -50.36% as of 2026 data. Recent news highlights a Supplier of the Year award from General Motors and a staged restart of its East Providence facility.

Outlook is mixed: strong analyst consensus (82.61% buy ratings) and projected revenue growth in energy-industrial and EV sectors support upside, but persistent losses, high RSI near 73, and negative cash flows pose significant risks. Investment appeal hinges on execution of guidance and path to profitability amid competitive and regulatory pressures.